SIGMA Pharmaceuticals ceo Mark Hooper yesterday sold more than 270,000 shares in the company, netting proceeds of $382,151.
According to an ASX disclosure notice Hooper sold the shares on market for about $1.40 each - about 11c more than yesterday's closing price of $1.285.
Hooper retains a large stake in Sigma, with the notice indicating after the sale he still holds over 34.5 million shares in the company.
The above article was sent to subscribers in Pharmacy Daily's issue from 03 Nov 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 03 Nov 16
